Early golexanolone treatment slows Parkinson’s progression in rats
Early treatment with the investigational small molecule golexanolone improved motor and cognitive function and eased signs of fatigue, anxiety, and…
Articles by Andrea Lobo
Vincere gets $5M MJFF grant to develop Parkinson’s treatment
Vincere Biosciences won a $5 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to…
APDA launches new awards program to sustain research
The American Parkinson Disease Association (APDA) has announced three recipients of its inaugural Bridge Funding…
Texas sets example with brain disease research investment: MJFF
Texas voters a a $3 billion state investment to support research into brain diseases such as Parkinson’s disease, a…
Cognitive measures may improve with buntanetap in Parkinson’s
In people with early Parkinson’s disease, buntanetap slowed cognitive decline, with the biggest gains…
$5M grant funds new strategy to clear Parkinson’s proteins
A $5 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) will help Booster Therapeutics develop…
Alector aims to seek FDA approval of Parkinson’s therapy in 2027
Alector said it is advancing the development of AL050, an enzyme replacement therapy for Parkinson’s disease, with an…
Trial testing light therapy device for Parkinson’s disease fully enrolled
Photopharmics has completed enrollment of a Phase 3 clinical trial testing Celeste, its light therapy device for Parkinson’s…
Jupiter’s oral resveratrol capsules cleared for testing in Parkinson’s
Jotrol, an oral formulation of the natural compound resveratrol, has been cleared for testing in people with Parkinson’s disease…
Women’s brains better protected from atrophy in REM disorder
Women with isolated REM sleep behavior disorder (iRBD), an early sign of Parkinson’s disease, exhibit fewer signs of early brain…